Back to ELVN
Novo Holdings A/S ELVN Position History
Enliven Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$45.8M
Q3 2026
Peak value
$50.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $22.8M |
| Q1 2026 | $50.2M |
| Q2 2026 | $50.8M |
| Q3 2026 | $45.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $45.8M | 1.00M | — | — |
| Q2 2026 | $50.8M | 1.00M | — | — |
| Q1 2026 | $50.2M | 1.28M | — | — |
| Q4 2025 | $22.8M | 1.48M | — | — |
Other funds holding ELVN
$449.6M
$394.2M
$343.9M
$326.4M
$312M
$310.6M
$294.5M
$261.1M